EUR-Lex Official Journal

Commission Implementing Regulation (EU) 2026/2099 on interoperable cross-border identification and authentication for electronic health data exchange

Establishes interoperable cross-border identification and authentication mechanism for natural persons, health professionals and healthcare providers for cross-border personal electronic health data exchange.

Commission Implementing Regulation (EU) 2026/2083 on MyHealth@EU

Commission Implementing Regulation (EU) 2026/2098 on minimum metadata elements for health data holder dataset descriptions under the European Health Data Space

Establishes minimum metadata elements and characteristics that health data holders must provide for dataset descriptions enabling secondary use of electronic health data under EHDS.

Commission Implementing Regulation (EU) 2026/977 laying down uniform quality management and procedural requirements for notified body conformity assessment activities under MDR and IVDR

Implementing regulation establishing uniform quality management and procedural requirements for notified bodies conducting conformity assessment under MDR and IVDR.

Commission Implementing Regulation (EU) 2026/771 establishing the European Health Data Space Board

Implementing regulation establishing the governance structure and operational procedures for the European Health Data Space Board.

Commission Delegated Regulation (EU) 2026/1451 amending MDR as regards exemptions from clinical investigation for implantable and Class III devices

Amendment to MDR exemption list for implantable and Class III devices from clinical investigation obligations.

Commission Implementing Decision (EU) 2026/901 on European standards for products under Regulation (EU) 2023/988, repealing Decision (EU) 2019/1698

Implementing decision establishing European standards for products under the medical devices framework, repealing the prior 2019 decision.

Commission Implementing Regulation (EU) 2026/2096 establishing procedures for the operation of the network for epidemiological surveillance

Commission Implementing Decision (EU) 2026/1819 amending instruments on authorisation holders and representatives for genetically modified organisms on the market

Amends multiple instruments to establish requirements for authorisation holders and their Union representatives for placing genetically modified organism products on the market.

Commission Implementing Regulation (EU) 2026/2097 on communicable diseases subject to epidemiological surveillance and case definitions

Regulation establishing communicable diseases and health issues subject to epidemiological surveillance and their case definitions, repealing Implementing Decision (EU) 2018/945.

Commission Implementing Regulation (EU) 2026/731 amending Implementing Regulation (EU) 2021/808 as regards transitional provisions and sampling

Amendment to pharmacovigilance sampling and transitional provisions under the Good Pharmacovigilance Practices Implementing Regulation.

Commission Recommendation (EU) 2026/510 on revising the European assessment framework for safe and sustainable by design chemicals and materials

Commission recommends revision of the European assessment framework for safe and sustainable by design chemicals and materials.

Commission Delegated Regulation (EU) 2026/1359 amending MDR as regards class IIb implantable devices exempted from technical documentation assessment

Amendment to MDR establishing exemptions from technical documentation assessment for specified class IIb implantable devices.

Regulation (EU) 2026/1388 on plants obtained by certain new genomic techniques and their products, amending Regulation (EU) 2017/625

New EU regulation establishing rules for plants developed using new genomic techniques and amending the official controls regulation.

Commission Delegated Regulation (EU) 2026/863 correcting language versions of Regulation (EC) No 1234/2008 on variations to marketing authorisations for medicinal products

Corrects language versions of the regulation governing variations to marketing authorisations for human medicinal products.

Commission Delegated Regulation (EU) 2026/908 amending Delegated Regulation (EU) 2021/630 on private attestation requirements for composite food products exempted from border controls

Amendment to food import control rules: expands exemptions from official border controls for certain composite food products and modifies private attestation requirements.

Commission Implementing Regulation (EU) 2026/857 amending Implementing Regulation (EU) 2025/2091 as regards the retention of samples of veterinary medicinal products that are repackaged for the purpose of parallel trade

Amendment to sample retention requirements for repackaged veterinary medicinal products in parallel trade.

Commission Implementing Regulation (EU) 2026/824 correcting Implementing Regulation (EU) 2025/854 as regards residue definitions for fosetyl-Al and trimethyl-sulfonium cation

Correction to pesticide residue definitions and commodity analysis lists for fosetyl-Al and trimethyl-sulfonium cation.

Commission Implementing Regulation (EU) 2026/765 on methods of sampling and analysis for official control of pesticide residues in food and feed

Regulation establishes methods for sampling and analysis of pesticide residues in food and feed, repealing Directive 2002/63/EC.

Commission Implementing Regulation (EU) 2026/748: coordinated multiannual control programme for pesticide residues in food, 2027–2029

Establishes a coordinated EU control programme for 2027–2029 to monitor pesticide residue compliance and consumer exposure in plant and animal food products.

Commission Recommendation (EU) 2026/1241 on monitoring quinolizidine alkaloids in lupins and lupin-derived food

Recommendation to monitor presence of quinolizidine alkaloids in lupins and lupin-derived food products.

Council Decision (EU) 2026/1966 on the EU position at the first meeting of the States Parties Committee for the Implementation of the International Health Regulations (2005)

Commission Implementing Decision (EU) 2026/738 revoking authorisation for genetically modified maize MON 87403

Revokes EU authorisation for placing on the market products containing, consisting of or produced from genetically modified maize MON 87403.

Commission Implementing Decision (EU) 2026/1023 establishing a programme for the exchange of staff of competent authorities with expertise in official controls on animals and goods entering the Union

Decision of the Quaestors of the European Parliament of 29 April 2026 amending the Annex to the decision of the Bureau of the European Parliament of 23 March 2011 entitled Rules concerning the ban on smoking on European Parliament's premises

Commission Implementing Decision (EU) 2026/2121 renewing authorisation for genetically modified maize MON 87460

Renewal of EU marketing authorisation for genetically modified maize MON 87460 under Regulation (EC) No 1829/2003.

Commission Implementing Decision (EU) 2026/2112: authorisation for genetically modified soybean GMB151 × DAS-44406-6

Marketing authorisation granted for products containing or produced from genetically modified soybean GMB151 × DAS-44406-6 under Regulation (EC) No 1829/2003.

Commission Implementing Decision (EU) 2026/2117: authorisation for genetically modified soybean MON 94313

Marketing authorisation granted for genetically modified soybean MON 94313 under Regulation (EC) No 1829/2003.

Commission Implementing Decision (EU) 2026/739 revoking authorisation for genetically modified maize MON 87419

Revokes EU authorisation for placing on the market products containing, consisting of or produced from genetically modified maize MON 87419.

Commission Implementing Decision (EU) 2026/1125 terminating renewal procedures for genetically modified cotton MON 88913, MON 15985, MON 1445, MON 531 × MON 1445 and MON 531

Renewal authorisation procedures for five genetically modified cotton varieties terminated under Regulation (EC) No 1829/2003.

Commission Implementing Decision (EU) 2026/1419: renewal of authorisation for genetically modified soybean MON 87705

Renewal of EU marketing authorisation for genetically modified soybean MON 87705 under Regulation (EC) No 1829/2003.

Commission Implementing Decision (EU) 2026/1185: authorisation for genetically modified soybean MON 94637

Authorises placing on the market of products containing, consisting of or produced from genetically modified soybean MON 94637 under Regulation (EC) No 1829/2003.

Commission Implementing Decision (EU) 2026/1417: renewal of authorisation for genetically modified maize NK603 × T25

Renewal of EU marketing authorisation for genetically modified maize NK603 × T25 under Regulation (EC) No 1829/2003.

Commission Implementing Decision (EU) 2026/1443: authorisation for placing on the market of genetically modified maize DP202216 x NK603 x DAS-40278-9

Marketing authorisation granted for genetically modified maize DP202216 x NK603 x DAS-40278-9 and specified sub-combinations under Regulation (EC) No 1829/2003.

Commission Implementing Decision (EU) 2026/518: Renewal of authorisation for genetically modified maize T25 (ACS-ZMØØ3-2)

Renewal of marketing authorisation for genetically modified maize T25 under Regulation (EC) No 1829/2003.

Commission Implementing Decision (EU) 2026/521: Renewal of authorisation for genetically modified cotton GHB614 × LLCotton25

Authorisation renewed for placing on the market of products containing or produced from genetically modified cotton GHB614 × LLCotton25 under Regulation (EC) No 1829/2003.

Commission Implementing Decision (EU) 2026/517: authorisation for genetically modified soybean DBN-09004-6

Marketing authorisation granted for products containing, consisting of or produced from genetically modified soybean DBN-09004-6 under Regulation (EC) No 1829/2003.

Commission Implementing Decision (EU) 2026/522: Renewal of authorisation for genetically modified cotton T304-40

Renewal of EU marketing authorisation for genetically modified cotton T304-40 under Regulation (EC) No 1829/2003.